Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
Luciano J. Costa, Yi Lin, Robert F. Cornell, Thomas G. Martin, Saurabh Chhabra, Saad Z. Usmani, Sundar Jagannath, Natalie S. Callander, Jesús G. Berdeja, Yubin Kang, Ravi Vij, Kelly Godby, Ehsan Malek, Amarendra Kumar Neppalli, Michaela Liedtke, Mark A. Fiala, Hong Tian, Satish Valluri, Jennifer Marino, Carolyn C. Jackson, Arnob Banerjee, Ankit Kansagra, Jordan M. Schecter, Shaji Kumar, Parameswaran Hari
Topics & Concepts
MedicineInternal medicinePopulationHazard ratioRefractory (planetary science)GastroenterologyConfidence intervalSurgeryBiologyAstrobiologyEnvironmental healthCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors